.

Make Better Decisions

  • Identify first generic entrants
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Federal Trade Commission
AstraZeneca
Cipla
UBS
Johnson and Johnson
McKesson
Mallinckrodt
McKinsey
Teva
Argus Health

Generated: November 20, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 020834

« Back to Dashboard
NDA 020834 describes ROGAINE EXTRA STRENGTH (FOR MEN), which is a drug marketed by Johnson And Johnson and is included in one NDA. It is available from two suppliers. Additional details are available on the ROGAINE EXTRA STRENGTH (FOR MEN) profile page.

The generic ingredient in ROGAINE EXTRA STRENGTH (FOR MEN) is minoxidil. There are eight drug master file entries for this compound. Fifty-six suppliers are listed for this compound. Additional details are available on the minoxidil profile page.

Summary for 020834

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:0
Therapeutic Class:Cardiovascular Agents
Formulation / Manufacturing:see details

Medical Subject Heading (MeSH) Categories for 020834

Suppliers and Packaging for NDA: 020834

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
ROGAINE EXTRA STRENGTH (FOR MEN)
minoxidil
SOLUTION;TOPICAL 020834 NDA Johnson & Johnson Consumer Inc. 42002-101 42002-101-02 1 BOTTLE, PLASTIC in 1 CARTON (42002-101-02) > 60 mL in 1 BOTTLE, PLASTIC
ROGAINE EXTRA STRENGTH (FOR MEN)
minoxidil
SOLUTION;TOPICAL 020834 NDA Johnson & Johnson Consumer Inc. 42002-101 42002-101-06 3 BOTTLE, PLASTIC in 1 CARTON (42002-101-06) > 60 mL in 1 BOTTLE, PLASTIC

Summary for product number 001

Active Rx/OTC/Discontinued:OTCDosage:SOLUTION;TOPICALStrength5%
Approval Date:Nov 14, 1997TE:RLD:Yes


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

QuintilesIMS
Medtronic
Teva
Deloitte
Chinese Patent Office
Covington
Harvard Business School
Cipla
McKesson
Novartis

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot